As for the patient RBCs, our western blot data show that C3 and C5 convertases were present on the membranes of all five PNH cases, and that they had been exposed to complement activation of both the classical and alternative pathways (Figure 4) despite eculizumab treatment. The gene discussed is C3; the disease is paroxysmal nocturnal hemoglobinuria.